—
C+
C+ The full Closelooknet — membership. Open the C+ overview

10X Genomics Inc (TXG) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for TXG, from the same nightly bakes the boards use. Research diary readings, not advice.

Mentioned on Closelooknet 1 piece · newest: Midday 10, “A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000” (2026-08-21)

Mentioned on Closelooknet

Where TXG appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
How it trades on rate days beta 1.58 to TLT · on the worst bond days it held up better than the market

How it trades on rate days

How TXG has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 1.58 — moves strongly with bonds for every 1% move in TLT (20+ year Treasuries), 10X Genomics Inc moved 1.58% on average · correlation 0.20 · higher than 97% of US names
  • Beta, last 3 months 1.75 about the same as over the year
  • On the 10 worst bond days +0.74% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +11.23% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Medical Devices · United States · 8 names with week and year-to-date

Peer group

Medical Devices · United States

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against TXG on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — 10X Genomics Inc

TXG in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
10x Genomics designs and sells instruments, consumables and software used to study individual cells and their spatial position within tissue. Its Chromium platform separates single cells for genetic analysis, while Visium and Xenium map gene activity back onto a tissue slide. Customers are academic, government and biopharmaceutical laboratories that use these tools for research rather than clinical diagnosis. The company is based in Pleasanton, California, and listed since 2019.
Where it sits in the stack
10x Genomics sits in the life-sciences tools and diagnostics corner of the healthcare sector our universe tracks, outside any Closelooknet index sleeve for now. It supplies the instruments and reagents that biopharmaceutical and academic labs consume for single-cell and spatial research, work that sits upstream of drug discovery rather than inside the AI compute build-out.
Who it is priced against
The instrument-and-consumables model invites comparison with other genomics tool makers such as Illumina and Pacific Biosciences, though none appears alongside it as a formal peer set here.
Why Closelooknet tracks it
It holds a seat in the Russell 1000 and has been named once in our diary, in a Midday 10 note listing large-cap stocks making new 52-week highs; it does not yet carry a Closelooknet score.
What the diary watches
Whether adoption of spatial and single-cell tools broadens beyond research labs into applied or clinical settings, which would change how the diary reads its growth.

10X Genomics Inc (TXG) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

FAQ · from the current data · as of 2026-09-26

Quick answers

What is 10X Genomics Inc (TXG)?

10X Genomics Inc trades as TXG on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is TXG in a Closelooknet index?

Not currently — 10X Genomics Inc is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-09-26.

Where does TXG trade against its moving averages?

Uptrend stack intact: Trades +42% vs the 50-day and +160.5% vs the 200-day average, 0.5% below the 52-week high and +668% off the 52-week low. Computed from daily closes. As of 2026-09-25 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does 10X Genomics Inc trade when bond yields rise?

Over the past year 10X Genomics Inc had a beta of 1.58 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 97% of US names. On the 10 sessions in which long bonds fell most it moved +0.74% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

Where has Closelooknet written about 10X Genomics Inc?

10X Genomics Inc appears in 1 Closelooknet piece, most recently Midday 10: A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000 (2026-08-21). What Closelooknet said most recently: Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG… (Midday 10, 2026-08-21). The "Mentioned on Closelooknet" block on this page lists the long reads, the reference entries and the dailies that name it.

What does 10X Genomics Inc do?

10x Genomics designs and sells instruments, consumables and software used to study individual cells and their spatial position within tissue. Its Chromium platform separates single cells for genetic analysis, while Visium and Xenium map gene activity back onto a tissue slide. Customers are academic, government and biopharmaceutical laboratories that use these tools for research rather than clinical diagnosis. The instrument-and-consumables model invites comparison with other genomics tool makers such as Illumina and Pacific Biosciences, though none appears alongside it as a formal peer set here.

Where does 10X Genomics Inc sit in the AI build-out?

10x Genomics sits in the life-sciences tools and diagnostics corner of the healthcare sector our universe tracks, outside any Closelooknet index sleeve for now. It supplies the instruments and reagents that biopharmaceutical and academic labs consume for single-cell and spatial research, work that sits upstream of drug discovery rather than inside the AI compute build-out. It holds a seat in the Russell 1000 and has been named once in our diary, in a Midday 10 note listing large-cap stocks making new 52-week highs; it does not yet carry a Closelooknet score.

What does this page show?

A live price chart with SMA overlays and drawing tools for TXG, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.